EPI Program Achievements

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	75,701,015 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	151,399,262 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	67,369,332 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	L.L
B02BX01	DICYNONE	B	Etamsylate - 250mg/2ml	250mg	Injectable solution	482,439 L.L
B02BX01	DICYNONE	B	Etamsylate - 500mg	500mg	Capsule	1,311,590 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	110,192,512 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	60,204,155 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 5mg	5mg (250KIU)	Injectable powder for solution+diluent	275,482,577 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	35,032,787 L.L
B02BD06	WILATE 500	BioHuman	Von Willebrand Factor - 500IU, Blood Coagulation Factor VIII - 500IU		Injectable powder for solution+diluent	32,399,164 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
B02BD04	OCTANINE F	BioHuman	Plasma coagulation factor IX, human - 500IU	500IU	Injectable freeze dried powder + diluent	31,425,075 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	27,390,281 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	76,080,435 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	149,006,276 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	298,171,406 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	40,480,699 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	79,869,612 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	14,098,526 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L

إنجازات البرنامج